Addition of IGF1 or IGF2 (100 ng/ml) can activate IGFR and AKT signaling in all the HCC cells tested (Hep3B, SK-Hep1, and PLC5) and HUVEC to a similar extent. This evidence concerns the gene IGF1R and hepatocellular carcinoma.